NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms

electroCore, Inc.’s ECOR gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain management and performance. The NFL and NFLPA are jointly awarding two research grants to independent medical researchers at the American Society of Pain and Neuroscience and Emory University.

The grants will fund investigations into alternative pain management methods that could benefit NFL players, and society at large. These awards are the second round chosen by the NFL-NFLPA joint pain management committee, which aims to facilitate research to better understand and improve potential alternative pain management treatments for NFL players.

nVNS will be used in a pilot study assessing non-invasive treatment of refractory post-concussion headache pain, led by Dr. Erika Petersen and researchers at the American Society of Pain and Neuroscience. The randomized study will compare nVNS and CBD in contact sport athletes experiencing post-traumatic headache to current standard of care treatment.

“We are thrilled to have been selected to be part of a study that focuses on alternative care options for pain management and performance,” stated Dr. Peter Staats, chief medical officer at electroCore. “Post-traumatic headache as an area of focus for electroCore is a natural progression from our cleared indications in primary headache. We are hopeful that nVNS will prove to be a pain management option for athletes, military personnel, or anyone suffering from pain associated with PTH.”

Benzinga Cannabis Capital Conference

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo by Louis Reed on Unsplash